INTEGRATIVE INDICATORS OF ENDOGENOUS INTOXICATION, INFLAMMATORY ACTIVITY, AND SPECIFIC REACTIVITY IN PATIENTS WITH COVID-19
DOI:
https://doi.org/10.11603/1681-2727.2024.3.14873Keywords:
Long-COVID, COVID-19, integrative indicators, endogenous intoxication, good health, inflammationAbstract
The aim of the study is to identify changes in blood laboratory parameters, integrative indicators of endogenous intoxication, inflammation, and specific reactivity in patients with coronavirus disease.
Patients and methods. The study included 77 patients with COVID-19, taking into account the inclusion and exclusion criteria. The comparison group consisted of 68 practically healthy people of the corresponding age. Laboratory blood tests were performed, on the basis of which integrative indicators of endogenous intoxication, inflammation and specific reactivity were calculated.
Results. The data of the general blood test showed no significant differences between the patients of the groups, the indicators remained within acceptable limits. A slight inflammatory reaction in patients with COVID-19, especially in the period from 3 to 6 months, is confirmed by an increase in the level of endogenous intoxication (LII, LSI, NLRI, HII) in the group of patients compared to healthy individuals. During the same period, there are signs of activation of the cellular immune system in response to the presence of latent bacterial infection or endogenous intoxication, which is confirmed by a decrease in inflammation activity (LGI, LESRI, CI). Reduced indices of nonspecific reactivity (RC, ILYM, AI) confirmed the activation of the cellular immune system, given the decrease in the number of lymphocytes relative to granulocytes. Changes in integrative indices did not depend on the presence of Long-COVID symptoms. In the period from 12 months after the coronavirus disease, the development of autoimmune processes is possible, since there was a tendency to decrease the indices of endogenous intoxication (NLRI, LSI) simultaneously with an increase in the indices of inflammatory activity (LGI, LESRI, TI) and indices of nonspecific reactivity (RC, Ilymph, AI).
References
Sweis, J. J. G., Alnaimat, F., Esparza, V., Prasad, S., Azam, A., Modi, Z., Al-Awqati, M., Jetanalin, P., Sweis, N. J., Ascoli, C., Novak, R. M., Rubinstein, I., Papanikolaou, I. C., & Sweiss, N. (2024). From acute infection to prolonged health consequences: Understanding health disparities and economic implications in long COVID worldwide. International Journal of Environmental Research and Public Health, 21(3), 325. https://doi.org/10.3390/ijerph21030325.
Proskura, T. (2021). Overview of persistent post-COVID syndrome. Praktykuiuchyi likar, (2), 53-57. https://plr.com.ua/index.php/journal/article/view/633 [in Ukrainian].
Hakem Zadeh, F. (2023). Long COVID: Complications, underlying mechanisms, and treatment strategies. Archives of Microbiology & Immunology, 07(02). https://doi.org/10.26502/ami.93650103.
Saienko, O., Chemych, M., & Svitailo, V. (2023). Long-COVID, neurological and cardiovascular disorders. Journal of Education, Health and Sport, 13(3), 381-393. https://doi.org/10.12775/jehs.2023.13.03.048.
Woldegiorgis, M., Cadby, G., Ngeh, S., Korda, R. J., Armstrong, P. K., Maticevic, J., Knight, P., Jardine, A., Bloomfield, L. E., & Effler, P. V. (2024). Long COVID in a highly vaccinated but largely unexposed Australian population following the 2022 SARS-CoV-2 Omicron wave: A cross-sectional survey. Medical Journal of Australia. https://doi.org/10.5694/mja2.52256.
Andreychyn, M. & Kopcha, V. (2023). Features of the course of COVID-19 in patients with chronic hepatitis B and C. Infektsiini khvoroby, (3), 31-37. https://doi.org/10.11603/1681-2727.2022.3.13479 [in Ukrainian].
Zahornacky, O., Porubčin, Š., Rovnakova, A., & Jarcuska, P. (2023). Multisystem inflammatory syndrome in adults associated with recent infection with COVID-19. Diagnostics, 13(5), 983. https://doi.org/10.3390/diagnostics13050983.
La Torre, F., Elicio, M. P., Monno, V. A., Chironna, M., Moramarco, F., Campanozzi, A., Civino, A., Cecinati, V., Vairo, U., Giordano, M., Milella, L., Loconsole, D., & Cardinale, F. (2023). Incidence and prevalence of multisystem inflammatory syndrome in children (MIS-C) in southern italy. Children, 10(5), 766. https://doi.org/10.3390/children10050766.
Levy, N., Koppel, J. H., Kaplan, O., Yechiam, H., Shahar-Nissan, K., Cohen, N. K., & Shavit, I. (2022). Severity and incidence of multisystem inflammatory syndrome in children during 3 sars-cov-2 pandemic waves in israel. Jama. https://doi.org/10.1001/jama.2022.8025.
Cherska, M., Kukharchuk, Kh., & Haiova, O. (2021). Mozhlyvosti korektsii postkovidnoho syndromu v rutynnii klinichnii praktytsi [Opportunities for correction of post-COVID syndrome in routine clinical practice]. Praktykuiuchyi likar, 10(1), 18-23. https://plr.com.ua/index.php/journal/article/view/612 [in Ukrainian].
Chemych, M. D., & Lishnevska, A. G. (2021). The role of galectin-9 in patients with chronic viral hepatitis c and its connection with the type of therapy, the degree of fibrosis, clinical, laboratory, autoimmune and integrative indicators. Wiadomości Lekarskie, 74(5), 1180-1188. https://doi.org/10.36740/wlek202105125.
Chemych, M., Cherkashyna, A., & Chemych, O. (2023). Features of changes in integrative indicators of endogenous intoxication, reactivity, inflammation activity in patients with chronic viral hepatitis and chronic renal failure. Eastern Ukrainian Medical Journal, 11(4), 461–470. https://doi.org/10.21272/eumj.2023;11(4):461-470.
Lishnevska, A. H., & Chemych, M. D. (2020). Changes in clinical, biochemical, immunological and integrative parameters in patients with chronic hepatitis C virus infection according to the virus genotype and the grade of activity. Zaporozhye Medical Journal, (4). https://doi.org/10.14739/2310-1210.2020.4.208363.
Lishnevska, A., Chemych, M., Chemych, O., & Chernetsky, I. (2023). Immunoreactivity and intoxication syndrome in patients with chronic viral hepatitis c. Bangladesh Journal of Medical Science, 22(3), 508-514. https://doi.org/10.3329/bjms.v22i3.65314.
Gottlieb, M., Spatz, E. S., Yu, H., Wisk, L. E., Elmore, J. G., Gentile, N. L., Hill, M., Huebinger, R. M., Idris, A. H., Kean, E. R., Koo, K., Li, S.-X., McDonald, S., Montoy, J. C. C., Nichol, G., O’Laughlin, K. N., Plumb, I. D., Rising, K. L., Santangelo, M., ... Arreguin, M. (2023). Long COVID clinical phenotypes up to six months after infection identified by latent class analysis of self-reported symptoms. Open Forum Infectious Diseases. https://doi.org/10.1093/ofid/ofad277.
Demko, Z. O., Yu, T., Mullapudi, S. K., Varela Heslin, M. G., Dorsey, C. A., Payton, C. B., Tornheim, J. A., Blair, P. W., Mehta, S. H., Thomas, D. L., Manabe, Y. C., & Antar, A. A. R. (2024). Two-Year longitudinal study reveals that long COVID symptoms peak and quality of life nadirs at 6–12 months postinfection. Open Forum Infectious Diseases, 11(3), 2328-8957. https://doi.org/10.1093/ofid/ofae027.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 В. С. Світайло, М. Д. Чемич
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Journal Infectious Disease (Infektsiini Khvoroby) allows the author(s) to hold the copyright without registration
Users can use, reuse and build upon the material published in the journal but only for non-commercial purposes
This journal is available through Creative Commons (CC) License BY-NC "Attribution-NonCommercial" 4.0
